Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Digital content for Angelini Pharma

Angelini Pharma

ANGELINI PHARMA

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2021

Product List 2021

VIDEO(s)

No Video

DIGITAL CONTENT

41 News

41 News

APIs // Active Pharmaceutical Ingredients

16 APIs, 10 USDMF, 5 NDC API, 10 Listed APIs

DEVELOPMENTS

7 Drug(s) in Development

7 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

79 Dossiers, 2 FDA Orange Book, 77 Europe

SERVICES

All Services, Analytical, API Manufacturing, API & Drug Product Development

All Services
Analytical
- 1 Analytical Method Development
API Manufacturing
API & Drug Product Development
- 7 API Development

INSPECTIONS & REGISTRATIONS

12 FDA, 14 EDQM, 1 Others, 1 GDUFA

Full View Screen

Full Screen View

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

PRNEWSWIRE

08 Dec 2022

Cenobamate is Now Available in France and Belgium

Cenobamate is Now Available in France and Belgium

BUSINESSWIRE

07 Dec 2022

Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma

Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma

PRESS RELEASE

22 Nov 2022

Cenobamate for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults

Cenobamate for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults

BUSINESSWIRE

01 Apr 2022

Angelini Pharma, a New Partner in Epilepsy

Angelini Pharma, a New Partner in Epilepsy

BUSINESSWIRE

25 Mar 2022

Angelini Pharma, a new partner in Epilepsy

Angelini Pharma, a new partner in Epilepsy

BUSINESSWIRE

14 Feb 2022

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

GLOBENEWSWIRE

28 Jul 2021

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

GLOBENEWSWIRE

28 Jul 2021

EC approval for Ontozry

EC approval for Ontozry

Selina McKee PHARMATIMES

06 Apr 2021

EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment

EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment

PHARMAFILE

01 Apr 2021

biophore-india-pharmaceuticals-pvt-ltd-m-2023-03-27

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search